Shield Therapeutics (STX.L) traded down -1.79 % during a 24 hours period ending at 05:47 PM Central Europe on Monday 26th. One Shield Therapeutics stock can currently be bought for about GBX 5.5 on popular exchanges. Current supply of Shield Therapeutics stocks is 1.1 bn. Shield Therapeutics has a current market capitalization of GBX 79 mn and approximately GBX 5.8 mn worth of Shield Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Shield Therapeutics has traded 13.4 % up. Simple moving average of last 200 days is at GBX 7.14. The highest price of past 52 weeks was recorded at GBX 12.5 on 01/16/2026. 52 weeks low was at GBX 3.7 on 08/07/2026.

Here is how related stocks have performed in the past 24 hours:

  • Eco Animal Health (EAH.L) traded flat 0 % and now trades at GBX 95.5. Current market capitalisation for Eco Animal Health is GBX 86.6 mn. Eco Animal Health has a current price to earnings ratio of 30.03.

  • Topps Tiles (TPT.L) traded down -2.78 % and now trades at GBX 35.2. Current market capitalisation for Topps Tiles is GBX 91.7 mn. Current price/earnings ratio for Topps Tiles is 13.83.

  • Maven Renovar Vct (MRV.L) traded flat 0 % and now trades at GBX 49.5. Maven Renovar Vct has a market capitalisation of GBX 83.5 mn.

  • Invinity Energy (IES.L) traded up 3.6 % and now trades at GBX 11.4. Invinity Energy has a market capitalisation of GBX 87.6 mn.

  • Jubilee Metals (JLP.L) traded down -6.52 % and now trades at GBX 2.15. Current market capitalisation for Jubilee Metals is GBX 92.9 mn.

About Shield Therapeutics

Shield Therapeutics PLC is a specialty pharmaceutical company from the United Kingdom, which has its main base in Gateshead. The company’s sector of operation is Health Care and its primary industry is Pharmaceuticals. Their mission revolves around the development and commercialization of secondary care-focused pharmaceuticals. The key late-stage products of Shield Therapeutics include an innovative oral medication for the treatment of iron deficiency anemia and an iron-based phosphate binder for addressing hyperphosphatemia issues. You can find more information about this company and its offerings on their official website, which is www.shieldtherapeutics.com . They are listed on the London Stock Exchange.